Altrix Tablets

cellulose, vegetable stearic acid, silica, croscarmellose sodium, vegetable megnesium stearate, cellulose coating, titanium oxide. 

Altrixa Tablets are contraindicated in patients with a known hypersensitivity to any the contained ingredients. Do not take this produc if you are presently taking mineral oil, unless directed by a licensed medical practitioner.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You may report side effects by calling Allegis Pharmaceuticals at 1-866-633-9033 or the FDA by calling 1-800-FDA-1088

Altrix Tablets are avaialble as white, round tablets with AL07 imprint and are available in 30 count bottles (28595-715-30). 

Manufactred in the USA for:

Allegis pharmaceuticals, LLC.

Canton MS 39046

Rev. 01/2024

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

† This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). 1-3 The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription. This is not an Orange Book product. This product may be administered only under a physician’s supervision and all prescriptions using this product shall be pursuant to state statutes as applicable.

The ingredients, indication or claims of this product are not to be construed to be drug claims.

1. Federal Register Notice of August 2, 1973 (38 FR20750) 2. Federal Register Notice of October 17, 1980 (45 FR69043, 69044)  3. Federal Register Notice of March 5, 1996 (61 FR 8760)